Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP645876.RAf94rcnYilG8Kv--JVoRrSpL4IFuQdlAdzVgC_6gA3V4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP645876.RAf94rcnYilG8Kv--JVoRrSpL4IFuQdlAdzVgC_6gA3V4130_assertion type Assertion NP645876.RAf94rcnYilG8Kv--JVoRrSpL4IFuQdlAdzVgC_6gA3V4130_head.
- NP645876.RAf94rcnYilG8Kv--JVoRrSpL4IFuQdlAdzVgC_6gA3V4130_assertion description "[Activation of JNK1 by anisomycin further increased Tau phosphorylation, and SP600125 (a JNK inhibitor) and PD-98059 (an MEK1/2 inhibitor) blocked Tau phosphorylation and NFT formation in these WOX1 knock-down cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645876.RAf94rcnYilG8Kv--JVoRrSpL4IFuQdlAdzVgC_6gA3V4130_provenance.
- NP645876.RAf94rcnYilG8Kv--JVoRrSpL4IFuQdlAdzVgC_6gA3V4130_assertion evidence source_evidence_literature NP645876.RAf94rcnYilG8Kv--JVoRrSpL4IFuQdlAdzVgC_6gA3V4130_provenance.
- NP645876.RAf94rcnYilG8Kv--JVoRrSpL4IFuQdlAdzVgC_6gA3V4130_assertion SIO_000772 15126504 NP645876.RAf94rcnYilG8Kv--JVoRrSpL4IFuQdlAdzVgC_6gA3V4130_provenance.
- NP645876.RAf94rcnYilG8Kv--JVoRrSpL4IFuQdlAdzVgC_6gA3V4130_assertion wasDerivedFrom befree-20150227 NP645876.RAf94rcnYilG8Kv--JVoRrSpL4IFuQdlAdzVgC_6gA3V4130_provenance.
- NP645876.RAf94rcnYilG8Kv--JVoRrSpL4IFuQdlAdzVgC_6gA3V4130_assertion wasGeneratedBy ECO_0000203 NP645876.RAf94rcnYilG8Kv--JVoRrSpL4IFuQdlAdzVgC_6gA3V4130_provenance.